Works matching AU Mall, Marcus A.


Results: 187
    1
    2
    3
    4

    Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis from Infancy through Adolescence.

    Published in:
    Annals of the American Thoracic Society, 2025, v. 22, n. 1, p. 93, doi. 10.1513/AnnalsATS.202404-396OC
    By:
    • Wielpütz, Mark O.;
    • Stahl, Mirjam;
    • Triphan, Simon M. F.;
    • Wucherpfennig, Lena;
    • Leutz-Schmidt, Patricia;
    • Gestewitz, Sonja;
    • Steinke, Eva;
    • Graeber, Simon Y.;
    • Kauczor, Hans-Ulrich;
    • Eichinger, Monika;
    • Puderbach, Michael U.;
    • Alrajab, Abdulsattar;
    • Schenk, Jens-Peter;
    • Sommerburg, Olaf;
    • Mall, Marcus A.
    Publication type:
    Article
    5

    Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2–5 Years of Age Homozygous for F508del-CFTR : A Phase 2, Open-Label Clinical Trial.

    Published in:
    Annals of the American Thoracic Society, 2024, v. 21, n. 11, p. 1550, doi. 10.1513/AnnalsATS.202402-201OC
    By:
    • Stahl, Mirjam;
    • Roehmel, Jobst;
    • Eichinger, Monika;
    • Doellinger, Felix;
    • Naehrlich, Lutz;
    • Kopp, Matthias V.;
    • Dittrich, Anna-Maria;
    • Sommerburg, Olaf;
    • Ray, Partha;
    • Maniktala, Anita;
    • Xu, Tu;
    • Conner, Sarah;
    • Joshi, Aniket;
    • Mascia, Molly;
    • Wielpütz, Mark O.;
    • Mall, Marcus A.
    Publication type:
    Article
    6

    Magnetic Resonance Imaging of Pulmonary and Paranasal Sinus Abnormalities in Children with Primary Ciliary Dyskinesia Compared to Children with Cystic Fibrosis.

    Published in:
    Annals of the American Thoracic Society, 2024, v. 21, n. 3, p. 438, doi. 10.1513/AnnalsATS.202305-453OC
    By:
    • Wucherpfennig, Lena;
    • Wuennemann, Felix;
    • Eichinger, Monika;
    • Schmitt, Niclas;
    • Seitz, Angelika;
    • Baumann, Ingo;
    • Roehmel, Jobst F.;
    • Stahl, Mirjam;
    • Hämmerling, Susanne;
    • Chung, Jaehi;
    • Schenk, Jens-Peter;
    • Alrajab, Abdulsattar;
    • Kauczor, Hans-Ulrich;
    • Mall, Marcus A.;
    • Wielpütz, Mark O.;
    • Sommerburg, Olaf
    Publication type:
    Article
    7
    8

    Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.

    Published in:
    Annals of the American Thoracic Society, 2023, v. 20, n. 8, p. 1144, doi. 10.1513/AnnalsATS.202208-684OC
    By:
    • Stahl, Mirjam;
    • Roehmel, Jobst;
    • Eichinger, Monika;
    • Doellinger, Felix;
    • Naehrlich, Lutz;
    • Kopp, Matthias V.;
    • Dittrich, Anna-Maria;
    • Lee, Christopher;
    • Sommerburg, Olaf;
    • Simon Tian;
    • Tu Xu;
    • Pan Wu;
    • Joshi, Aniket;
    • Ray, Partha;
    • Duncan, Margaret E.;
    • Wielputz, Mark O.;
    • Mall, Marcus A.
    Publication type:
    Article
    9

    Longitudinal Magnetic Resonance Imaging Detects Onset and Progression of Chronic Rhinosinusitis from Infancy to School Age in Cystic Fibrosis.

    Published in:
    Annals of the American Thoracic Society, 2023, v. 20, n. 5, p. 687, doi. 10.1513/AnnalsATS.202209-763OC
    By:
    • Wucherpfennig, Lena;
    • Wuennemann, Felix;
    • Eichinger, Monika;
    • Schmitt, Niclas;
    • Seitz, Angelika;
    • Baumann, Ingo;
    • Stahl, Mirjam;
    • Graeber, Simon Y.;
    • Jaehi Chung;
    • Schenk, Jens-Peter;
    • Alrajab, Abdulsattar;
    • Kauczor, Hans-Ulrich;
    • Mall, Marcus A.;
    • Sommerburg, Olaf;
    • Wielpütz, Mark O.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging.

    Published in:
    Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1161891
    By:
    • Wucherpfennig, Lena;
    • Wuennemann, Felix;
    • Eichinger, Monika;
    • Seitz, Angelika;
    • Baumann, Ingo;
    • Stahl, Mirjam;
    • Graeber, Simon Y.;
    • Shengkai Zhao;
    • Jaehi Chung;
    • Schenk, Jens-Peter;
    • Alrajab, Abdulsattar;
    • Kauczor, Hans-Ulrich;
    • Mall, Marcus A.;
    • Sommerburg, Olaf;
    • Wielpütz, Mark O.
    Publication type:
    Article
    17
    18
    19

    Ion mobility-tandem mass spectrometry of mucin-type O-glycans.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46825-4
    By:
    • Bechtella, Leïla;
    • Jin Chunsheng;
    • Fentker, Kerstin;
    • Ertürk, Güney R.;
    • Safferthal, Marc;
    • Polewski, Łukasz;
    • Götze, Michael;
    • Graeber, Simon Y.;
    • Vos, Gaël M.;
    • Struwe, Weston B.;
    • Mall, Marcus A.;
    • Mertins, Philipp;
    • Karlsson, Niclas G.;
    • Pagel, Kevin
    Publication type:
    Article
    20
    21
    22
    23

    Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.

    Published in:
    Journal of Inherited Metabolic Disease, 2010, v. 33, p. 263, doi. 10.1007/s10545-010-9174-7
    By:
    • Sommerburg, Olaf;
    • Lindner, Martin;
    • Muckenthaler, Martina;
    • Kohlmueller, Dirk;
    • Leible, Svenja;
    • Feneberg, Reinhard;
    • Kulozik, Andreas;
    • Mall, Marcus;
    • Hoffmann, Georg
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).

    Published in:
    Infection, 2020, v. 48, n. 4, p. 619, doi. 10.1007/s15010-020-01464-x
    By:
    • Kurth, Florian;
    • Roennefarth, Maria;
    • Thibeault, Charlotte;
    • Corman, Victor M.;
    • Müller-Redetzky, Holger;
    • Mittermaier, Mirja;
    • Ruwwe-Glösenkamp, Christoph;
    • Heim, Katrin M.;
    • Krannich, Alexander;
    • Zvorc, Saskia;
    • Schmidt, Sein;
    • Kretzler, Lucie;
    • Dang-Heine, Chantip;
    • Rose, Matthias;
    • Hummel, Michael;
    • Hocke, Andreas;
    • Hübner, Ralf H.;
    • Opitz, Bastian;
    • Mall, Marcus A.;
    • Röhmel, Jobst
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Dextromethorphan inhibits collagen and collagen-like cargo secretion to ameliorate lung fibrosis.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 778, p. 1, doi. 10.1126/scitranslmed.adj3087
    By:
    • Khan, Muzamil M.;
    • Galea, George;
    • Jung, Juan;
    • Zukowska, Joanna;
    • Lauer, David;
    • Tuechler, Nadine;
    • Halavatyi, Aliaksandr;
    • Tischer, Christian;
    • Haberkant, Per;
    • Stein, Frank;
    • Jung, Ferris;
    • Landry, Jonathan J. M.;
    • Khan, Arif M.;
    • Oorschot, Viola;
    • Becher, Isabelle;
    • Neumann, Beate;
    • Muley, Thomas;
    • Winter, Hauke;
    • Duerr, Julia;
    • Mall, Marcus A
    Publication type:
    Article
    38

    Gene signature driving invasive mucinous adenocarcinoma of the lung.

    Published in:
    EMBO Molecular Medicine, 2017, v. 9, n. 4, p. 462, doi. 10.15252/emmm.201606711
    By:
    • Guo, Minzhe;
    • Tomoshige, Koichi;
    • Meister, Michael;
    • Muley, Thomas;
    • Fukazawa, Takuya;
    • Tsuchiya, Tomoshi;
    • Karns, Rebekah;
    • Warth, Arne;
    • Fink‐Baldauf, Iris M;
    • Nagayasu, Takeshi;
    • Naomoto, Yoshio;
    • Xu, Yan;
    • Mall, Marcus A;
    • Maeda, Yutaka
    Publication type:
    Article
    39

    SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.

    Published in:
    Eurosurveillance (15607917), 2021, v. 26, n. 34, p. 1, doi. 10.2807/1560-7917.ES.2021.26.34.2100184
    By:
    • Theuring, Stefanie;
    • Thielecke, Marlene;
    • van Loon, Welmoed;
    • Homme, Franziska;
    • Hülso, Claudia;
    • von der Haar, Annkathrin;
    • Körner, Jennifer;
    • Schmidt, Michael;
    • Böhringer, Falko;
    • Mall, Marcus A.;
    • Rosen, Alexander;
    • von Kalle, Christof;
    • Kirchberger, Valerie;
    • Kurth, Tobias;
    • Seybold, Joachim;
    • Mockenhaupt, Frank P.
    Publication type:
    Article
    40
    41

    Compromised DNA repair is responsible for diabetes‐associated fibrosis.

    Published in:
    EMBO Journal, 2020, v. 39, n. 11, p. 1, doi. 10.15252/embj.2019103477
    By:
    • Kumar, Varun;
    • Agrawal, Raman;
    • Pandey, Aparamita;
    • Kopf, Stefan;
    • Hoeffgen, Manuel;
    • Kaymak, Serap;
    • Bandapalli, Obul Reddy;
    • Gorbunova, Vera;
    • Seluanov, Andrei;
    • Mall, Marcus A;
    • Herzig, Stephan;
    • Nawroth, Peter P
    Publication type:
    Article
    42
    43
    44

    Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 11, p. 1338, doi. 10.1164/rccm.202310-1836OC
    By:
    • Loske, Jennifer;
    • Völler, Mirjam;
    • Lukassen, Sören;
    • Stahl, Mirjam;
    • Thürmann, Loreen;
    • Seegebarth, Anke;
    • Röhmel, Jobst;
    • Wisniewski, Sebastian;
    • Messingschlager, Marey;
    • Lorenz, Stephan;
    • Klages, Sven;
    • Eils, Roland;
    • Lehmann, Irina;
    • Mall, Marcus A.;
    • Graeber, Simon Y.;
    • Trump, Saskia
    Publication type:
    Article
    45

    Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 3, p. 299, doi. 10.1164/rccm.202308-1525OC
    By:
    • Ramsey, Bonnie;
    • Correll, Christoph U.;
    • DeMaso, David R.;
    • McKone, Edward;
    • Tullis, Elizabeth;
    • Taylor-Cousar, Jennifer L.;
    • Chu, Chenghao;
    • Volkova, Nataliya;
    • Ahluwalia, Neil;
    • Waltz, David;
    • Tian, Simon;
    • Mall, Marcus A.
    Publication type:
    Article
    46

    Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 1, p. 59, doi. 10.1164/rccm.202301-0084OC
    By:
    • Goralski, Jennifer L.;
    • Hoppe, Jordana E.;
    • Mall, Marcus A.;
    • McColley, Susanna A.;
    • McKone, Edward;
    • Ramsey, Bonnie;
    • Rayment, Jonathan H.;
    • Robinson, Phil;
    • Stehling, Florian;
    • Taylor-Cousar, Jennifer L.;
    • Tullis, Elizabeth;
    • Ahluwalia, Neil;
    • Anna Chin;
    • Chenghao Chu;
    • Mengdi Lu;
    • Tao Niu;
    • Weinstock, Tanya;
    • Ratjen, Felix;
    • Rosenfeld, Margaret
    Publication type:
    Article
    47

    Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 11, p. 1361, doi. 10.1164/rccm.202202-0392OC
    By:
    • Mall, Marcus A.;
    • Brugha, Rossa;
    • Gartner, Silvia;
    • Legg, Julian;
    • Moeller, Alexander;
    • Mondejar-Lopez, Pedro;
    • Prais, Dario;
    • Pressler, Tacjana;
    • Ratjen, Felix;
    • Reix, Philippe;
    • Robinson, Paul D.;
    • Selvadurai, Hiran;
    • Stehling, Florian;
    • Ahluwalia, Neil;
    • Arteaga-Solis, Emilio;
    • Bruinsma, Bote G.;
    • Jennings, Mark;
    • Moskowitz, Samuel M.;
    • Noel, Sabrina;
    • Tian, Simon
    Publication type:
    Article
    48

    Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two Alleles.

    Published in:
    2022
    By:
    • Graeber, Simon Y.;
    • Vitzthum, Constanze;
    • Pallenberg, Sophia T.;
    • Naehrlich, Lutz;
    • Stahl, Mirjam;
    • Rohrbach, Alexander;
    • Drescher, Marika;
    • Minso, Rebecca;
    • Ringshausen, Felix C.;
    • Rueckes-Nilges, Claudia;
    • Klajda, Jan;
    • Berges, Julian;
    • Yin Yu;
    • Scheuermann, Heike;
    • Hirtz, Stephanie;
    • Sommerburg, Olaf;
    • Dittrich, Anna-Maria;
    • Tümmler, Burkhard;
    • Mall, Marcus A.;
    • Yu, Yin
    Publication type:
    journal article
    49

    Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 5, p. E1, doi. 10.1164/rccm.202110-2249oc
    By:
    • Graeber, Simon Y.;
    • Vitzthum, Constanze;
    • Pallenberg, Sophia T.;
    • Naehrlich, Lutz;
    • Stahl, Mirjam;
    • Rohrbach, Alexander;
    • Drescher, Marika;
    • Minso, Rebecca;
    • Ringshausen, Felix C.;
    • Rueckes-Nilges, Claudia;
    • Klajda, Jan;
    • Berges, Julian;
    • Yin Yu;
    • Scheuermann, Heike;
    • Hirtz, Stephanie;
    • Sommerburg, Olaf;
    • Dittrich, Anna-Maria;
    • Tümmler, Burkhard;
    • Mall, Marcus A.
    Publication type:
    Article